Trial Profile
A double-blind, randomized, multicenter, and active treatment-controlled trial for efficacy and safety of cilostazol in acute ischemic stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms CAIST
- 01 Jul 2011 Results published in Cerebrovascular Diseases.
- 22 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.